Please login to the form below

Not currently logged in
Email:
Password:

growth hormone disorder

This page shows the latest growth hormone disorder news and features for those working in and with pharma, biotech and healthcare.

Merck completes €15m Spanish biotech facility expansion

Merck completes €15m Spanish biotech facility expansion

Merck completes 15m Spanish biotech facility expansion. Enlarged Tres Cantos site will help meet demand for fertility and growth hormone drugs. ... Merck has completed a 15m investment project at its biotech facility in Spain that will allow it to up

Latest news

  • Novartis plans filings for acromegaly candidate Novartis plans filings for acromegaly candidate

    A phase III trial of Novartis' somatostatin analogue Signifor has suggested it could be effective for the growth hormone disorder acromegaly. ... Acromegaly occurs when the pituitary gland produces excessive levels of growth hormone (GH), leading to

  • EMA confirms safety profile for growth hormone

    EMA confirms safety profile for growth hormone. Regulator investigated somatropin-containing medicines after study raised mortality fears. ... Medicines that contain the growth hormone are used to treat growth failure, growth hormone deficiency,

  • A tailored approach to paediatric education

    European Lilly affiliates, including France, Spain, Italy, Ireland, The Netherlands and Portugal, as well as in to other therapy areas such as Attention Deficit Hyperactivity Disorder (ADHD) and growth hormone deficiency.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics